Modified Penn Spasm Frequency Scale
The Modified Penn Spasm Frequency Scale (PSFS) is a patient self-reported measure that quantifies involuntary muscle spasms through two components: Part 1 assesses spasm frequency on a 0-4 scale, and Part 2 evaluates spasm severity, also on a 0-4 scale.
Scale Structure and Scoring
The PSFS consists of two distinct parts that capture different dimensions of spasticity:
Part 1 - Spasm Frequency:
- 0 = No spasms
- 1 = Mild spasms induced by stimulation
- 2 = Infrequent full spasms occurring less than once per hour
- 3 = Spasms occurring more than once per hour
- 4 = Spasms occurring more than 10 times per hour
Part 2 - Spasm Severity:
- 1 = Mild
- 2 = Moderate
- 3 = Severe
Clinical Application and Reliability
The PSFS demonstrates excellent reliability in chronic spinal cord injury populations, with intra-rater reliability of 0.822 at 5-10 days and inter-rater reliability of 0.862 within 3 days for Part 1 alone 1. When combining both parts, reliability remains substantial (intra-rater 0.812, inter-rater 0.857), though slightly lower than Part 1 alone 1.
The scale is administered as a self-report questionnaire where patients document their own spasm frequency and severity, making it practical for both clinical assessment and research outcomes 1.
Clinical Relevance and Correlation with Other Measures
The PSFS captures phasic spasticity (involuntary muscle spasms) rather than tonic spasticity (velocity-dependent resistance to stretch). This distinction is critical because:
- PSFS correlates poorly with clinical examination scales like the Modified Ashworth Scale, with correlations typically below 0.4 2
- The weak correlation between different spasticity measures suggests they assess distinct components of the upper motor neuron syndrome 2
- Patient-rated spasm frequency (PSFS) shows better association with pain levels (ρ=0.33, p=0.01) compared to physician-rated scales like the Modified Ashworth Scale 3
Practical Considerations
Use the PSFS when you need to:
- Track phasic spasticity (involuntary spasms) over time
- Assess patient-perceived spasm burden
- Evaluate correlation between spasms and functional interference or pain
- Monitor treatment response to interventions targeting spasm frequency (e.g., levetiracetam reduced mean Penn Spasm scores from 2.7 to 0.9 in multiple sclerosis patients) 4
Do not rely on PSFS alone for comprehensive spasticity assessment, as it does not capture tonic spasticity, resistance to passive movement, or other components of the upper motor neuron syndrome 2. The scale should be part of a multidimensional assessment that includes clinical examination measures when evaluating overall spasticity burden.
The PSFS is particularly valuable because it captures the patient's lived experience of spasms, which correlates with functional interference (r=0.407) and painful spasms (r=0.312) better than clinician-rated scales 2.